Opinion: Upgrading Cancer Prevention

Preemptive detection and intervention will be key to easing the growing burden of cancer, particularly in developing countries.

Written byDavid Lane
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WIKIMEDIA, 14 MOSTAFA&ZEYADMore than two centuries ago, the brilliant English surgeon Percivall Pott became intrigued by a scrotal cancer that disproportionately afflicted former chimney sweeps. Pott argued in a book initially published in 1775 that exposure to soot caused the disease, making him the first person to identify an environmental cause of cancer. His observation helped lay the foundations of occupational medicine and, notably, suggested that the chimney sweeps’ cancer could be prevented.

Today we know significantly more about the causes of cancer, and these are, if nothing else, as complex as the disease. How exactly genes and environment interact to propel malignancy is only just beginning to be worked out, but one thing is clear: our habits play a big role. We know, for example, that about half of all diagnosed cancers are fueled by lifestyle choices, such as smoking, alcohol use, and poor diet, but the answer is probably more nuanced than we realize. What constitutes a good versus poor diet, for instance? A huge study published in JAMA Internal Medicine earlier this month (March 9) reported that people who eat fish have a 43 percent reduced risk of colon cancer compared with those who eat ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies